American Conference Institute’s 3rd Annual Conference on: Life Sciences Compliance – Boot Camp
30 January – 1 February 2017
The discussion will focus on:
- Compliance guidelines for participating in Medicare, Medicaid, VA and DoD programs
- Price reporting authorities, programs and vocabulary
- CMS
- Medicaid
- Best Price: AMP
- Medicare: Parts B and D
- ASP
- ASP +6
- CAP
- WAMP
- VA/DOD
- GSA, FSS
- Special pricing and reimbursement compliance concerns for devices
- Devising price reporting strategy assessments
- When and how companies best communicate changes in price reporting methodologies to appropriate authorities
- Red flags that regulators and enforcers look at when investigating price reporting fraud and abuse
- How to best involve your compliance department in price and reporting and reimbursement matters
For more information and to register visit the American Conference website.
People
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…